Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the 'Arbeitsgemeinschaft Internistische Onkologie' (AIO-PK01 (Q38402469)
Jump to navigation
Jump to search
scientific article published on 07 July 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the 'Arbeitsgemeinschaft Internistische Onkologie' (AIO-PK01 |
scientific article published on 07 July 2012 |
Statements
1 reference
Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the 'Arbeitsgemeinschaft Internistische Onkologie' (AIO-PK01 (English)
1 reference
Ludwig Fischer von Weikersthal
0 references
Volker Heinemann
1 reference
Dirk Waldschmidt
1 reference
Erika Kettner
1 reference
Angela Märten
1 reference
Cornelia Winkelmann
1 reference
Stefan Klein
1 reference
Georgi Kojouharoff
1 reference
Thomas C Gauler
1 reference
Michael R Clemens
1 reference
Michael Geissler
1 reference
Tim F Greten
1 reference
Oleg Rubanov
1 reference
Gerold Baake
1 reference
Thomas Höhler
1 reference
Yon D Ko
1 reference
Andreas Jung
1 reference
Sascha Neugebauer
1 reference
Stefan Boeck
1 reference
7 July 2012
1 reference
1 reference
62
1 reference
5
1 reference
751-759
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference